Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...
Twelve months after surgery, 39% of men in the NeuroSAFE arm had no or mild erectile dysfunction. In those men who had standard surgery, this was 23%. A year after their operation, only 38% of those ...
If you think you have erectile dysfunction, or ED, a good first step is to talk with your doctor. The treatment you need will depend on what's causing it. And to find the cause, your doctor may ask ...
Health and Me on MSN
Minimally invasive focal therapy for prostate cancer promises fewer side effects than surgery or radiotherapy
A targeted focal therapy can now help prostate cancer patients as it promises same outcomes with fewer side effects than ...
A groundbreaking study published this July reveals that a targeted treatment for prostate cancer is just as effective as ...
Erectile dysfunction (ED) impacts an estimated 18 million men in the U.S. alone, yet it is rarely discussed openly. John Smith, DO, a urologist at University of Utah Health, addresses the barriers to ...
Lately, it may feel like you can't go a day without seeing an ad on TV or online about erectile dysfunction (ED). Despite the ...
Dr Ahmed Yousef, the consultant urologist who led a team of specialists who conducted the region’s first erectile dysfunction procedure last year was fully booked for months on end. Well, that is ...
Twelve months after surgery, 39% of men in the NeuroSAFE arm had no or mild erectile dysfunction 3. In those men who had standard surgery this was 23%. A year after their operation, only 38% of those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results